What do p53 proteins do?

A gene that makes a protein that is found inside the nucleus of cells and plays a key role in controlling cell division and cell death. Mutations (changes) in the p53 gene may cause cancer cells to grow and spread in the body.

Do cancer cells produce too much p53 protein?

“When Rbm38 suppresses p53, organisms develop tumors. Knocking out Rbm38 increases p53, which we thought might be a good thing. But too much p53 suppresses cell-cycle progression, causing cell death, premature aging and even cancer.”

Why is p53 high in cancer cells?

In this review, we consider available evidence suggesting that mutant p53 proteins can favor cancer cell survival and tumor progression by acting as homeostatic factors that sense and protect cancer cells from transformation-related stress stimuli, including DNA lesions, oxidative and proteotoxic stress, metabolic …

How does p53 work as a tumor suppressor?

If the DNA can be repaired, p53 activates other genes to fix the damage. If the DNA cannot be repaired, this protein prevents the cell from dividing and signals it to undergo apoptosis. By stopping cells with mutated or damaged DNA from dividing, p53 helps prevent the development of tumors.

What happens to p53 in cancer?

TP53 gene mutations change single amino acids in p53, which impair the protein’s function. Without functioning p53, cell proliferation is not regulated effectively and DNA damage can accumulate in cells. Such cells may continue to divide in an uncontrolled way, leading to tumor growth.

What are tumor suppressor proteins?

Definition. Tumour-suppressor proteins act to alleviate the potential for cancer and tumour formation by modulating cell growth either through negative regulation of the cell cycle or by promoting apoptosis.

Is p53 an oncogene or a tumor suppressor gene?

As such, p53 has been described as “the guardian of the genome” because of its role in conserving stability by preventing genome mutation. Hence TP53 is classified as a tumor suppressor gene.

Does phospholipase D stabilize the mutant p53 in MDA-MB-231 cells?

The human breast cancer cell line MDA-MB-231, which has high levels of a mutant p53, has high levels of phospholipase D (PLD) activity, which provides a survival signal in these cells when deprived of serum growth factors. We report here that the mutant p53 in MDA-MB-231 cells is stabilized by the elevated PLD activity in these cells.

What is the MDA-MB-231 cell line used to model?

The MDA-MB-231 cell line (isolated at M D Anderson from a pleural effusion of a patient with invasive ductal carcinoma) is commonly used to model late-stage breast cancer. This cell line is ER, PR, and E-cadherin negative and expresses mutated p53. In microarray profiling, the MDA-MB-231 cell genome clusters with the basal subtype of breast cancer.

Is HP1α downregulated in MDA MB-231?

HP1α is believed to counteract tumor progression since it is known to be downregulated in the invasive TNBC cell lines MDA-MB-231 and HS578T when compared with the ER/PR positive MCF7 and T47D [99]. Moreover, HP1α overexpression reduces the in vitro invasive phenotype of MDA-MB-231 [100].

Does the MEK inhibitor U0126 suppress p53 in MDA-MB-231 cells?

As shown in Figure 2b, the MEK inhibitor U0126 suppressed MAP kinase phosphorylation and p53 expression. These data indicate that the PLD-dependent increase in p53 in MDA-MB-231 cells is dependent on the MAP kinase pathway. Elevated expression of p53 in MDA-MB-231 cells is dependent on MAP kinase and independent of mTOR.